R Systems International's recent acquisition of Novigo Solutions adds strong Agentic AI and automation capabilities, enhancing cross-sell potential and deepening presence in the Middle East and South India.
NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Systematix Report
We initiate coverage on R Systems International Ltd. with a Buy rating and a target price of Rs 507, based on 27 times PE on CY26E earnings per share.
R Systems International is entering a new growth phase, supported by renewed leadership, operational focus, and the strategic backing of its new promoter, Blackstone. The company has steadily moved beyond its legacy image to become a credible player in product engineering, digital transformation, and AI adoption.
Developments over the last year include-
client additions through the Blackstone network,
strengthening of leadership, and
launch of OptimaAI, its proprietary AI platform, which is gaining early traction.
Their recent acquisition of Novigo Solutions adds strong Agentic AI and automation capabilities, enhancing cross-sell potential and deepening presence in the Middle East and South India.
We expect growth to accelerate meaningfully over CY25-26, supported by increased client activity,
better deal wins, and
expansion in high-potential areas like GCC setups and AI solutions.
We estimate 17%/21/30% CAGR in revenue/Ebitda/PAT, respectively, over CY24–26E, with Ebitda margin expected to remain stable.
The company is strategically reinvesting gains towards strengthening its technology offerings, driving deal conversions, and expanding its client base.
Click on the attachment to read the full report:
DISCLAIMER
This report is authored by an external party. NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.
RECOMMENDED FOR YOU

Gland Pharma Gets Yes Securities' 'Add' Upgrade; Sees U.S., Cenexi Business as Key Growth Drivers


Indegene Gets 'Add' Rating As ICICI Securities Initiates Coverage


Love Reading NDTV Profit? Here's How To Add Us As A Preferred Source On Google

.png?rect=0%2C0%2C3500%2C1969&w=75)
Trent Q1 Review — Dolat Capital Maintains 'Add', Says Rich Valuations Leave Limited Room To Err
